Considerations for generic oncology FDG-PET/CT protocol preparation in drug development

William A Hallett1, R Paul Maguire, Timothy J McCarthy

  • 1GlaxoSmithKline plc, London, UK.

Idrugs : the Investigational Drugs Journal
|October 31, 2007
PubMed